Madely Health Headlines Commentary for June 8, 2012
Source:
Alzheimer’s Vaccine Trial a Success
Reference:
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer’s disease: randomised, double-blind, placebo-controlled, first-in-human study. The Lancet Neurology